Cargando…

A Case Report of Kratom-Induced Psychiatric Decompensation

INTRODUCTION: Kratom (Mitragyna speciosa) is an herb found in South East Asia belonging to the Rubiacea family, the active constituents being Mitragynine and 7-hydroxymitragynine. Sold as a dietary supplement in the form of a leaf, tablet, and powder, it has been gaining popularity as a natural supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrels, E., Gill, G., Mitra, S., Korenis, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567650/
http://dx.doi.org/10.1192/j.eurpsy.2022.2139
_version_ 1784809453227343872
author Garrels, E.
Gill, G.
Mitra, S.
Korenis, P.
author_facet Garrels, E.
Gill, G.
Mitra, S.
Korenis, P.
author_sort Garrels, E.
collection PubMed
description INTRODUCTION: Kratom (Mitragyna speciosa) is an herb found in South East Asia belonging to the Rubiacea family, the active constituents being Mitragynine and 7-hydroxymitragynine. Sold as a dietary supplement in the form of a leaf, tablet, and powder, it has been gaining popularity as a natural supplement to alleviate pain, anxiety, depression, and manage opioid withdrawal symptoms. Our case report centers around a patient encountered with high-dose Kratom use who presented to our Psychiatric ER with psychosis. OBJECTIVES: The objectives of this case report are to raise awareness regarding the use of a newly popular substance easily available over-the-counter and the potential impacts it has on mental health. METHODS: PubMed was searched for the criteria Kratom AND Intellectual Disability, with a secodary search for Kratom AND Psychosis. RESULTS: A 29-year-old male with a past psychiatric history of Schizoaffective Disorder, Borderline Intellectual Functioning, Polysubstance Use, ADHD, and six prior suicide attempts was brought to the Psychiatric ED by ambulance activated by his mother for severe psychiatric decompensation following ingestion of 270 pills of Kratom over the course of three days. CONCLUSIONS: This case report further increases awareness of the dangers of Kratom use as well as brings to light the psychoactive properties of Kratom. This case report exposes areas where research can further expand understanding regarding the impacts Kratom can have on psychiatric populations. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9567650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95676502022-10-17 A Case Report of Kratom-Induced Psychiatric Decompensation Garrels, E. Gill, G. Mitra, S. Korenis, P. Eur Psychiatry Abstract INTRODUCTION: Kratom (Mitragyna speciosa) is an herb found in South East Asia belonging to the Rubiacea family, the active constituents being Mitragynine and 7-hydroxymitragynine. Sold as a dietary supplement in the form of a leaf, tablet, and powder, it has been gaining popularity as a natural supplement to alleviate pain, anxiety, depression, and manage opioid withdrawal symptoms. Our case report centers around a patient encountered with high-dose Kratom use who presented to our Psychiatric ER with psychosis. OBJECTIVES: The objectives of this case report are to raise awareness regarding the use of a newly popular substance easily available over-the-counter and the potential impacts it has on mental health. METHODS: PubMed was searched for the criteria Kratom AND Intellectual Disability, with a secodary search for Kratom AND Psychosis. RESULTS: A 29-year-old male with a past psychiatric history of Schizoaffective Disorder, Borderline Intellectual Functioning, Polysubstance Use, ADHD, and six prior suicide attempts was brought to the Psychiatric ED by ambulance activated by his mother for severe psychiatric decompensation following ingestion of 270 pills of Kratom over the course of three days. CONCLUSIONS: This case report further increases awareness of the dangers of Kratom use as well as brings to light the psychoactive properties of Kratom. This case report exposes areas where research can further expand understanding regarding the impacts Kratom can have on psychiatric populations. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567650/ http://dx.doi.org/10.1192/j.eurpsy.2022.2139 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Garrels, E.
Gill, G.
Mitra, S.
Korenis, P.
A Case Report of Kratom-Induced Psychiatric Decompensation
title A Case Report of Kratom-Induced Psychiatric Decompensation
title_full A Case Report of Kratom-Induced Psychiatric Decompensation
title_fullStr A Case Report of Kratom-Induced Psychiatric Decompensation
title_full_unstemmed A Case Report of Kratom-Induced Psychiatric Decompensation
title_short A Case Report of Kratom-Induced Psychiatric Decompensation
title_sort case report of kratom-induced psychiatric decompensation
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567650/
http://dx.doi.org/10.1192/j.eurpsy.2022.2139
work_keys_str_mv AT garrelse acasereportofkratominducedpsychiatricdecompensation
AT gillg acasereportofkratominducedpsychiatricdecompensation
AT mitras acasereportofkratominducedpsychiatricdecompensation
AT korenisp acasereportofkratominducedpsychiatricdecompensation
AT garrelse casereportofkratominducedpsychiatricdecompensation
AT gillg casereportofkratominducedpsychiatricdecompensation
AT mitras casereportofkratominducedpsychiatricdecompensation
AT korenisp casereportofkratominducedpsychiatricdecompensation